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Abstract
The zinc finger transcription factor Smad-interacting protein-1 (Sip1; Zeb2, Zfhx1b) plays an important role during
vertebrate embryogenesis in various tissues and differentiating cell types, and during tumorigenesis. Previous biochemical
analysis suggests that interactions with several partner proteins, including TGFb family receptor-activated Smads, regulate
the activities of Sip1 in the nucleus both as a DNA-binding transcriptional repressor and activator. Using a peptide aptamer
approach we mapped in Sip1 its Smad-binding domain (SBD), initially defined as a segment of 51 amino acids, to a shorter
stretch of 14 amino acids within this SBD. Modelling suggests that this short SBD stretch is part of an extended a-helix that
may fit the binding to a hydrophobic corridor within the MH2 domain of activated Smads. Four amino acids (two polar Q
residues and two non-polar V residues) that form the tandem repeat (QxVx)2 in this 14-residue stretch were found to be
crucial for binding to both TGFb/Nodal/Activin-Smads and BMP-Smads. A full-length Sip1 with collective mutation of these
Q and V residues (to A) no longer binds to Smads, while it retains its binding activity to its cognate bipartite target DNA
sequence. This missense mutant Sip1(AxAx)2 provides a new molecular tool to identify SBD (in)dependent target genes in
Sip1-controlled TGFb and/or BMP (de)regulated cellular, developmental and pathological processes.
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Introduction
The Transforming Growth Factor type b (TGFb) system
controls many cellular processes including proliferation versus
differentiation, (de)adhesion, epithelial-mesenchymal transition
(EMT), and cell migration and accompanying cell shape changes
[1–4]. TGFb family signaling, including via Nodal and Bone
Morphogenetic Proteins (BMPs), is also crucial during embryo-
genesis in induction, patterning and morphogenesis, and for the
regulation of stem/progenitor cells and their niche in the embryo
and the adult animal [5,6]. In each of these normal processes, the
signaling by this ligand-receptor system together with its intracel-
lular signal transduction involving Smad proteins and protein-
kinase based non-Smad signaling, is under tight control at multiple
levels and by various mechanisms [7–10]. The Smads engage in
interactions with a wide variety of proteins outside and inside the
nucleus. Many of the nuclear partners for receptor-activated
Smads are important transcription factors or co-factors that steer
cell fate determination and cellular behaviour [6,11]. Understand-
ing how each of these many Smad-interacting proteins (SIPs)
precisely function when bound to Smads, and whether they can
also function Smad-independently, remains both in the Smad and
SIP fields a relevant challenge.
Smad-interacting protein-1 (Sip1, also named Zeb2 and
Zfhx1b) was one of the first identified SIPs [12]. In most assays
involving its expression from transfected vectors, full-length Sip1
represses the transcription of endogenous candidate target genes
or target gene promoter based reporters. Based on candidate
target promoter analysis and in vitro DNA-binding, full-length Sip1
binds to DNA with two zinc fingers, present in each of its two zinc
finger rich clusters, to a separated repeat of mainly CACCT(G) in
gene regulatory regions [13]. In this way Sip1 down regulates E-
cadherin (Cdh1) mRNA levels [14,15]. Cdh1 is also regulated by
many other factors and mechanisms during EMT (e.g. Snail family
zinc finger repressors, Rho and micro-RNAs; for a review, see
[16]) [17,18] and high Sip1 levels in several Cdh1-low/null
epithelial-derived tumors are indicative for bad prognosis [19–21].
Mouse Sip1 is a 1215 amino acid (aa)-long protein (1214 in
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human) containing several functional domains. Binding of Sip1 to
both the TGFb/Nodal/Activin-Smads (Smad2 and 3) and BMP-
Smads (Smad1, 5 and 8) in ligand-stimulated cells depends on its
51 aa-long Smad-binding domain (SBD) located in-between the
two zinc finger clusters [12]. In addition, a short segment located
in the extreme N-terminal part of Sip1 serves binding to the
chromatin remodelling complex NuRD. This NuRD-interaction
motif (NIM) of Sip1 is mutated - and no longer binds NuRD - in a
patient with mild symptoms of Mowat-Wilson syndrome (MWS)
[22]. It is unknown whether the SBD and NIM of Sip1 function
independently of each other or not.
Mutations in the SIP1-encoding gene ZFHX1B cause MWS
(MIM #235730), which is characterized by severe intellectual
disability, typical craniofacial malformation and in most patients
epilepsy and Hirschsprung disease [23–25]. Studies with various
Sip1 knockout mice show that the Hirschsprung disease and the
craniofacial malformations have their origin in defects in neural
crest cells. Additional studies in mutant mice also pointed at
defects in sensory neurogenesis, in particular in dorsal root ganglia,
and some MWS patients are indeed less sensitive to pain [26–29].
Sip1 also regulates early neural differentiation in vivo and in
cultured embryonic stem cells [30–35], and is later an important
factor in the timing of neurogenesis and gliogenesis in the cortex of
the embryonic mouse brain [36]. Specific loss of Sip1 in
GABAergic interneurons affects their fate and disrupts their
guided migration from the ventral telencephalon to the cortex in
the mouse brain [37,38]. During myelinogenesis, Sip1 exerts anti-
BMP activity and thereby promotes myelination [39]. It achieves
this by binding to activated BMP-Smads that normally induce a
set of BMP-induced genes encoding inhibitors of myelinogenesis,
leading to Sip1/Smad-mediated repression of these same genes.
Sip1 can also activate transcription (for a discussion, see [40]). For
example, during myelinogenesis Sip1 directly activates transcrip-
tion of Smad7, which provides additional negative control of
inhibitory BMP signaling during myelinogenesis [39]. These
observations raise important questions about Sip1 and SIP
transcription factors in general: do they exert an anti-BMP activity
also within other cell types (in culture and in vivo)? Does their
activity always occur in concert with Smads? If not, what is then
the subset of SIP target genes that depends on Smad-SIP
interaction?
Peptide aptamers are recombinant proteins obtained through
in-frame insertion of short peptides in an appropriately selected
scaffold protein. They are good tools to document protein-protein
interaction via specific domains or, when expressed in cells at
sufficiently high levels, to interfere with protein function mainly by
sequestering their cognate targets [41]. Aptamers also provide
possibilities to screen for agents (drugs, synthetic compounds) that
mimic the structure of the identified peptides and that can be
tested for their therapeutic potential [42,43]. Thioredoxin (TrxA)
of E. coli is frequently used as scaffold because a loop encompassing
its active site is ideally suited for displaying conformationally
constrained peptides [41,43]. Such TrxA-based aptamers have
meanwhile been used to identify structural elements or important
regions of other proteins and SIPs, including FoxH1, CBP, Lef1
and SARA [44,45].
Using a combination of peptide aptamers and structural
bioinformatics, we identified a specific 14 aa-long linear sequence
within the SBD of Sip1 that represents the minimal binding
segment for Smads. Mutagenesis of 4 amino acids only, within this
stretch, in full-length Sip1 abolished Sip1 binding to Smads. Such
new mutant Sip1 will facilitate the identification of Sip1’s Smad-
(in)dependent actions and target genes in future functional studies.
Materials and Methods
Cell Culture and Plasmid Transfection
Human embryonic kidney (HEK) 293T cells were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
4.5 g/l glucose, 10% (v/v) foetal bovine serum and 1% (v/v) L-
Glu (both from Gibco, Life Technologies). NMe cells were grown
as described in [46]. Plasmids were transfected using Lipofecta-
mine-2000 (Life Technologies) according to the manufacturer’s
instructions.
Plasmids and Cloning
For expression of the Trx-SBD aptamers in mammalian cells,
we inserted the cDNA encoding the entire mouse Sip1 SBD
(named A1; Figure 1A) or fragments thereof (A2 to A5), amplified
by PCR using primers carrying 59-RsrII sites, into the unique RsrII
site of pCI-NLS-HA-Trx (kindly provided by F. M. Hoffmann,
Madison, USA; see [44]). The sequences encoding the aptamers
A6, A7 and A8 were obtained by single-strand oligonucleotide
annealing and inserted into pCI-NLS-HA-Trx as described above.
The cloning of full-length, wild-type (WT) Myc-tagged Sip1 in
expression vectors has been described [15]. The full-length
Sip1(AxAx)2 mutant cDNA was obtained by PCR using comple-
mentary primers carrying the desired mutations together with
primers respectively covering the ATG initiation codon and the
stop codon of mouse Sip1 cDNA. This mutant cDNA was inserted
in pCS3-myc (adding an in-frame N-terminal c-Myc tag to Sip1)
and then used for transfection of HEK293T or NMe cells. The
mutant cDNA was also inserted between the ClaI and NotI sites in
pCIG (pCAGGS-IRES-eGFP; see [38]) for focal electroporation
experiments in embryonic brain slices. In the latter approach, the
eGFP coding region was lost with the cloning. As control a pCIG-
Sip1WT encoding vector was used. The Sip1ZnF mutant no
longer binds to DNA [13]. Briefly, it is mutated in essential
residues of 2 zinc fingers of the N-terminal zinc finger cluster and
of 2 zinc fingers of the C-terminal zinc finger cluster of Sip1. To
visualize electroporated cells in the brain slices the plasmid
pCALNL (Addgene) was used.
DNA-IP
Complementary sense and anti-sense oligodeoxyribonucleotides
containing the Sip1-binding E-boxes of the Activin-inducible
Xbra2 gene [12,13] were resuspended in 16 annealing buffer
(50 mM Tris-HCl pH7.8, 10 mM MgCl2) to a final concentration
of 400 ng/ ml and incubated for 2 min at 95uC, followed by
15 min at 70uC, 15 min at 37uC, 10 min at 25uC and, finally,
15 min at 4uC. Annealing was confirmed by electrophoresis in 2%
agarose gel. The annealed oligonucleotides were then incubated
with pre-cleared Streptavidin conjugated magnetic beads (Dyna-
beads M280, Life Technologies) for 1 hour at 4uC on an orbital
shaker at low speed. Nuclear versus cytoplasmic fractionation was
performed on transfected HEK293T cells using the Ne-Per kit
(Pierce) following the manufacturer’s protocol with the modifica-
tion that the nuclear lysate was homogenized by passing 5 times
the protein extract through a 22-G needle every 10 minutes. 15 mg
of nuclear lysate were subjected, in parallel with the cytoplasmic
fraction, to SDS-polyacrylamide gel electrophoresis to verify the
presence of Sip1 or Sip1 mutant proteins in these cell fractions.
Lamin-C was used as nuclear marker protein and loading control.
The prepared nuclear extracts were added to the beads-
oligonucleotides and incubated for 16 hours at 4uC with gentle
shaking. They were then washed with PBS containing 0.2% BSA,
and the bound proteins were eluted from the beads with
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Figure 1. TGFb and BMP activated Smads bind to the same aa459–472 segment of (mouse) Sip1. A) Sip1 SBD sequence conservation in
five different vertebrates, and schematic representation of the peptide aptamers used in this study. The numbering shown for the aptamers at the
right applies to the mouse protein sequence; the histograms reflect strong versus weaker conservation amongst the animal species. The aptamer A1
represents the insert in the Trx protein scaffold of the entire 51 aa-long SBD, as defined previously [12]; the aptamers A2–A8 are C- and/or N- terminal
truncations of A1. B–D) Co-IP experiments in extracts from transfected HEK293T cells show that both TGFb (B) and BMP (C,D) activated (Flag-tagged)
Smads bind only to the aptamers A1, A3 and A4, indicating that the shared region shared between A3 and A4 is responsible for the interaction. E)
Flag-tagged Smad3 and Smad1 proteins were specifically bound by a 14 aa-long sequence represented by the A6 aptamer (sequence in red in panel
A), and comprehending the tandem repeat (QxVx)2 (for details, see main text). The activation of the TGFb family pathway was assessed using p-
p38MAPK or pAKT levels; Tubulin detection was used as loading control. Panel B was acquired using a Digital Chemiluminescence System (Bio-Rad;
see Materials and Methods).
doi:10.1371/journal.pone.0076733.g001
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56Laemmli loading buffer at 95uC for 10 min, and afterwards
separated by electrophoresis in 6% SDS-polyacrylamide gels.
Co-immunoprecipitation, Western Blotting and
Antibodies
Transfected HEK293T cells were stimulated 24 hours after
transfection with recombinant human (rh) TGFb1 (5 ng/ml; R&D
Systems) or rhBMP4 (25 ng/ml; R&D Systems). After 1.5 hour,
the cells were lysed using lysis buffer (170 mM NaCl, 10 mM
EDTA, 50 mM Tris-HCl pH7.4, 0.5% NP-40, supplemented with
proteases inhibitors (Roche) and phosphatase inhibitors (1 mM
NaF, 10 mM NaVO3)). 500 mg of protein from these extracts were
incubated overnight with magnetic G-protein-coupled beads
(Dynabeads) bound to anti-HA or anti-FLAG antibody. Elution
of the captured proteins from these beads was done using
56Laemmli sample buffer and heating at 95uC for 10 min.
Protein lysates (15 mg in total for the detection of Flag-Smads,
phosphoAKT (pAKT) and Tubulin; 60 mg in total for detection of
HA-tagged aptamers) were separated by SDS-PAGE and then
transferred to a PVDF Membrane (GE Healthcare). The blots
were then incubated with skimmed non-fat dry milk (5% w/v) in
TBS containing 0.25% Tween–20 for 1 hour and then incubated
for 16 hours at 4uC with one of the following antibodies (at the
indicated dilutions): anti-phosphoSmad5 (detecting pSer463/
pSer465 of Smad1 as well) (Epitomics/AbCam; 1:1000), anti-
phosphoAKT (Cell Signaling; 1:1000), anti-phospho p38MAPK
(Cell Signaling; 1:1000), anti-myc (clone 9E10, Santa Cruz;
1:1000), anti-FLAG M2 and biotinylated anti-FLAG M2 (Sigma;
1:2500), anti-HA (CoVance; 1:1000), anti-tubulin (ProBio;
1:3000), anti-Lamin C (Novocastra; 1:1000). We tried several
antibodies for detection of phosphoSmad3 (pSmad3) levels,
unfortunately none of the commercially available antibodies that
we tested was good enough to verify accurately the status of
Smad3 activation in Western Blots. Therefore, we decided to use
pAKT and p-p38MAPK as an alternative marker for TGFb
pathway activation. After three washes of 15 min each, the blots
were incubated with the appropriate Horse Radish Peroxidase
(HRP)-conjugated secondary antibody (1:25000, Jackson Immu-
noResearch). For detection of the biotinylated Flag antibody a
Streptavidin HRP-conjugated secondary antibody was used
(Perkin Elmer). Signals were visualized using ECL reagent
(Amersham) and developed using Fuji X films (Fuji) or Digital
Chemiluminescence System (Bio-Rad).
Luciferase Assay
2.56104 HEK293T cells were seeded per well of a 96-well plate
and transfected with pGL3-Cdh1 plasmids containing the
promoter region (2308/+21, where the transcription start site is
+1) of human Cdh1 [14], and one of the Sip1-encoding vectors
and/or a vector encoding a constitutively active (c.a., i.e. ligand-
independent) variant of the Smad2/3-activating Alk4 receptor
(c.a.Alk4). The cells were lysed by repeated freeze/thawing in
Tropix lysis buffer (100 mM KH2PO4 pH7.8, 0.2% Triton X-100,
1 mM DTT) 24 hours after transfection. For luciferase quantifi-
cation the Luciferase Assay Substrate (from Promega) was used.
Normalization was to b-galactosidase activity produced from a co-
transfected pCMV-bGal vector (Clontech) and assayed using
Galscreen Tropix (Applied Biosystems). Typically, three indepen-
dent experiments were performed in quadruplicate. Absolute
values were standardized to the (respective) controls (mock= 1).
3D-modelling
The mouse Sip1 sequence aa437–487, encompassing the
initially defined 51 aa-long SBD [12], was submitted to the
Phyre2 server and several pdb files were obtained [47]. Each file
with the different predicted structure was then analysed using
PyMol software (PyMOL Molecular Graphics System, Version
1.5.0.4 Schro¨dinger, LLC). Next, we subjected the Sip1 sequence
aa417–503 to a One-to-One threading modelling using as
template structure the d1vpra1.pdb file. Volume occupancy was
visualized using PyMol software, while electrostatic potential
analysis and RMSD calculations were performed with VMD
software [48,49].
Stress Fiber Quantification in Cultured Cells
12.56104 NMe cells were seeded in each well of a 24-well plate
coated with PBS 20.1% gelatine, and then transfected in
suspension with ON-TARGET plus SmartPOOL siRNA that
targets mouse Sip1 (25 nM final concentration; L-059671-00-
0005, Dharmacon) or a control Non-Targeting siRNA (siCTRL,
Dharmacon) and the plasmid of interest at a final concentration of
1.2 mg/ml. 16 hours after transfection, the cells were stimulated
with 5 ng/ml of TGFb1 for 48 hours, adding the same
concentration of fresh TGFb1 upon medium replacement after
24 hours. Cells were then fixed in PBS containing 2%
paraformaldehyde for 10 min on ice, quenched in 50 mM NH4Cl
two times for 5 min, and then incubated with Blocking Reagent
(Roche) in PBS20.2% Triton X-100 (PBST) for 1 hour. After two
washes of 5 min each with PBST, the slides were incubated with
anti-Sip1 antiserum (GeneScript; 1:100) or anti-Myc antibody
(1:500) in Blocking Reagent in PBST for 1.5 hour. After three
washes with PBST, the cells were incubated for 1 hour with anti-
phalloidin (488-conjugated, 1:5000; Alexa Fluor) and a secondary
anti-mouse Cy3 conjugated antibody (Alexa Fluor). The cells were
then stained with phalloidin to detect the formation of stress fibers.
At least 4 different and independent regions of each slide were
analysed by microscopy. The area covered by stress fibers (green
staining; number of pixels/mm2) was quantified using ImageJ
software. The acquired images were converted to 8-bit grayscale
and the foreground/background colors were inverted. The
threshold was adjusted until the phalloidin fluorescence was
excluded by the threshold limits. Stained areas were measured in
pixels setting the scale of the image in mm. Statistics was
performed using the Student T-test.
Animals – Ethics Statement
We confirm that all animal experiments were done according to
the latest regulations set by the Belgian authorities that follow the
European Parliament and Council Directive 2010/63/EU on the
protection of animals used for scientific purposes. This is certified
by authorization to our laboratory via certificate LA1210584 from
the Belgian Ministry of Public Health, Safety of the Food Chain
and Environment, including from its inspection department and its
deontological committee (file 11/2010; August 4, 2011). We
confirm we also obtained approval by the Animal Care
Committee of KU Leuven, the acting Institutional Animal Care
and Use Committee (IACUC) of KU Leuven. Mouse lines were
maintained in a CD1/Swiss background. Homozygous Sip1 (exon7)
‘‘floxed’’ mice [50] were crossed with homozygous RCEfl/fl (which
stands for ROSA26RCAG-loxP-stop-loxP-EGFP; [51]) reporter mice. Sip1fl/
fl;RCEfl/fl mice were mated with Nkx2-1-Cre mice [52] that were
heterozygous for Sip1 to obtain Cre;Sip1fl/KO (KO=knockout)
mutant embryos (referred to as Sip1;RCE|Nkx2-1).
Mapping of the Smad-Binding Domain in Sip1/Zeb2
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e76733
Focal Electroporation in Embryonic Brain Slices
Focal electroporation was done as described previously [38].
E13.5 brains from Sip1;RCE|Nkx2-1 embryos were dissected in
ice-cold Hepes-buffered Leibovitz’ L15-medium supplemented
with glucose, and then embedded in 4% low-melting point
agarose. Coronal slices (300 mm) were sectioned using a vibratome
(HM650V, Microm). Injection in the MGE was performed with
the aforementioned plasmids (0.5 mg/ ml) and 4% Fast Green
(Sigma-Aldrich). The Cre-dependent dsRed CALNL plasmid
(1 mg/ ml) was used as control or co-electroporated to label the
neurons in which Sip1 was deleted by Cre. Injected slices were
electroporated using a cover square platinum plate electrode
(CUY701P20L) and a petridish square platinum plate electrode
(CUY701P20E) (both from Sonidel) via a BTX electroporator
(ECM830, Harvard Apparatus) (5 pulses of 150 V and 5 ms
duration with 100 ms intervals). The electroporated slices were
transferred to poly-L-Lysin (Sigma-Aldrich) and Laminin (Sigma-
Aldrich) coated inserts (Millicell Cell Culture insert, pore size
0,4 mm, Millipore) and cultured for 3 days in vitro (DIV) using an
air-interface protocol [53]. Slices were fixed with 4% paraformal-
dehyde, mounted on slides and analyzed via confocal microscopy
(Nikon A1R Eclipse Ti). For each condition, we quantified the
total amount of RFP-positive (RFP+) cells in the slice and
calculated the proportion of RFP+ neurons that reached the cortex
using ImageJ software. Statistical significance of the difference
between each condition was calculated using the Chi-square test.
Results
Peptide Aptamers Identify a Stretch of 14 Amino Acids
within the 51 Amino Acids-long SMAD-binding Domain
(SBD) Necessary to Confer Binding of Sip1 to Smads
The initially mapped SBD of Sip1 was a 51 aa-long linear
sequence encompassing aa437–487 of mouse Sip1. This SBD is
necessary and sufficient to interact with the MH2 i.e. C-terminal
domain of Smad1 in GST-based pull-down assays, with the MH2
domain of Smad2 and 3 and with the MH2 domain of Smad1, 5
and 8 in yeast two-hybrid assay, and in BMP pathway-activated
mammalian cells [12,31; Dzwonek, Conidi, van Grunsven,
Huylebroeck and Verschueren, unpublished results). We wanted first
to locate the minimal segment in this SBD needed for binding to
activated Smads. Truncated SBD peptides (numbered A1–A5, see
Figure 1A) were inserted at the cDNA level in HA-tagged Trx in a
transient expression vector for mammalian cells [44]. Next, we
tested by co-immunoprecipitation (co-IP) whether these SBD-Trx
proteins were able to bind to Smads. For this, HA-tagged aptamer
and FLAG-tagged Smad encoding constructs were transfected to
HEK293T cells, stimulated with TGFb1 or BMP4, as well as
unstimulated cells. Only the A1 (the 51 aa-long SBD), A3 (lacking
the last 19 aa of these 51 aa) and A4 (lacking the first 24 aa of SBD)
SBD-Trx polypeptides bound to Smad3 in conditions of activa-
tion, as documented by the levels of phosphorylated p-p38MAPK
(Figure 1B). These results, obtained by using Sip1 SBD-based
aptamers, confirm our previous observations with full-length, N-
terminally tagged Sip1 (Dzwonek, Conidi, Verschueren and
Huylebroeck, unpublished results) that Sip1 binds to activated Smads
only. Interestingly, the BMP-activated Smads tested here, i.e.
Smad1 and Smad5 (Figure 1C,D), were bound by these same
three aptamers. This indicates that the region shared between A3
and A4, i.e. 14 aa (aa459–472), is necessary for the interaction of
Sip1 with Smads in ligand-stimulated cells.
To narrow down further the sequence necessary for Smad
binding, we designed additional aptamers covering segments of the
A3/A4 sequence, i.e. A6, which precisely co-incides with the
segment 459–472; A7, a more N-terminally located segment in
A3, but absent from A4; and A8, a C-terminal segment in A4, but
absent from A3 (see Figure 1A). A new round of co-IP experiments
showed that only A6 was able to bind to activated Smads (see
Figure 1E for Smad3 and Smad1; pAKT levels were used here to
verify TGFb or BMP4 pathways activation. We therefore
conclude that aa459–472 (i.e. the sequence of A6; see Figure 1A)
within mouse Sip1 is the minimal linear SBD sequence tested here
that is able to mediate interaction with activated Smads.
A Predicted, Structurally Conserved Element of the Sip1
Smad-binding Domain is Necessary for the Interaction
with the MH2 Domain of Activated Smads
In silico alignment of the Sip1 SBD sequence from different
species indicated that the identified 14 aa-long stretch, which
corresponds to mouse Sip1 aa459–472 and is identical to aptamer
A6 (Figure 1A), has a high level of conservation score within the 51
aa-long SBDs. To identify potential structures and candidate
residues that are crucial for and/or mediate Sip1-Smad interac-
tion, we applied 3D modelling, leading to a structural represen-
tation (see Figure 2) that however remains hypothetical and needs
future experimental confirmation. The mouse Sip1 SBD sequence
(as aa437–487) was submitted to the Phyre2 bioinformatics server
[47]. This yielded several, but related top score potential
secondary and tertiary structures. Subsequent analysis of these
with PyMol software suggested a common structure (d1vpra.pdb,
see Figure S1A) based on this long SBD sequence. This
d1vpra.pdb model was used as template in a one-to-one threading
process [47] against the longer aa417–503 segment of mouse Sip1.
This approach revealed that an a-helix encompassing the aa459–
472 stretch is the central structural element of the SBD (Figure 2A,
A9). This element, and in particular the minimal, shorter SBD
stretch identified in this study, contains specific residues that may
mediate protein-protein interaction. Q461 and Q465 protrude
from the a-helix, as shown by surface representation (Figure 2B,
B9). Furthermore, this a-helix could according to our preliminary
analyses (Leslie, Conidi and Huylebroeck, unpublished results) fit well
in the hydrophobic corridor present in the Smad3 MH2 domain
that is formed by its triple helix bundle and b-strand (Figure S1B)
where important residues for the interaction with Sip1 and other
SIPs have been identified [54]. This domain and corridor are
accessible in activated Smads, wherein the auto-inhibitory
interaction between the MH1 and MH2 domain is indeed
dissolved.
Q461 and Q465 are part of a dual repeat of 4 amino acids with
Q and V in position 1 and 3, which is highly conserved in Sip1
from different vertebrates (Figure 1A). We refer to this 8aa-long
sequence as the (QxVx)2 motif in Sip1 and its SBD (in red in
Figure 2). We then collectively mutated the amino acids Q461,
V463, Q465, V467 to Alanine in a full-length mouse Sip1
backbone (hereafter named Sip1(AxAx)2 mutant). These substitu-
tions would ideally affect Sip1-Smad interaction only, i.e. without
disrupting the predicted structure and folding of this segment in
Sip1. To confirm this, we submitted the sequence of such mutant
SBD to the Phyre2 server for a one-to-one threading modelling
and enquired for its fit with the previously obtained predicted
structure. As shown in Figure 3(A, A9), the a-helix would be
preserved in the mutant SBD, but the anticipated key Q and V
residues would no longer protrude from the surface (Figure 3B, B9)
due to the absence of the polar Q residues in particular. Figure 4
shows the electrostatic properties of the predicted WT and mutant
(AxAx)2 SBD: the negative charges (red areas) in the region of the
Q461 to Q465 of WT Sip1 are lost in the mutant. When we
superimpose the WT and the SBD mutant structures we obtained
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a significant root mean square deviation (RMSD), a commonly
used measure of dissimilarity or error in protein structure, for the
a-helices of the aa459–472 region (RMSD=0.12) (Figure 5A).
The randomness of the in silico predicted models, however, infers
on the general RMSD value, as also confirmed by the disordered
regions shown in Figure 5B (arrowheads).
Full-length Sip1(AxAx)2 Mutant Protein Fails to Bind to
Activated Smad Proteins and Still Binds to its DNA Target
Sequence
We first tested if the Sip1(AxAx)2 mutant binds to Smads. Co-IP
experiments in extracts of transfected ligand-stimulated HEK293T
cells demonstrated that the interaction between full-length (N-
terminally Myc-tagged) Sip1(AxAx)2 and activated (Flag-tagged)
BMP-Smads and TGFb-Smads was lost (Figure 6A; Smad1 and
Smad3 are shown here, respectively; pAkt detection is included
here to confirm pathway activation). In order to verify that the
inserted mutations affect Smad binding while keeping other
domains functional, in particular the function of each of the two
zinc finger clusters in DNA binding, we performed a DNA pull-
down experiment (see also [14]), using biotinylated double-
stranded deoxyoligonucleotides containing an acknowledged
Sip1-binding DNA target sequence. The promoter region of
Xbra2 confers responsiveness to Activin; it contains a cognate Sip1
Figure 2. 3D modelling of the Sip1 SBD sequence and structural features of the 459–472 sequence. Two orientations of the same model
are depicted. Panels A and A9 represent the ‘‘cartoon model’’ highlighting the structural elements present in the SBD of WT Sip1. Panels B and B9 are
surface representation with volume occupied by the domain. C and C9 show the combination of panels A/A9 and B/B9. The SBD structure was
obtained after one-to-one threading process using the dvpra1a.pdb structure against the 417–503 sequence of Sip1. The overall structure of the SBD
shows the presence of several a-helixes bundled and coiled-coil regions in a closed conformation. The (QxVx)2 sequence (as part of aa459–472; red/
yellow a-helix panels A and A9) is on the solvent-exposed surface and two polar chains protrude from this a-helix, suggesting a potential role as
mediator of the interaction with the hydrophobic corridor in the Smad MH2 domain. In blue: the previously defined SBD aa437–487; red: aa459–472
(with the (QxVx)2 sequence); yellow: Q461, V463, Q465 and V467 residues (see main text for further details). X,Y and Z axes are depicted showing the
orientation of the two sets of panels.
doi:10.1371/journal.pone.0076733.g002
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binding site that is necessary and sufficient, and needs to be intact,
in the early Xenopus embryo for the proper and brief spatial-
temporal control of Xbra2 [53], just prior to the segregation of the
Xbra and Sip1 expression domains into mesoderm and neuroec-
toderm, respectively [55–57]. We selected a 153 bp-long sequence
of the Xbra2 gene promoter (see Materials and Methods), wherein
the half sites for DNA binding by Sip1 reside, and where these are
separated by 24 bp [13,55]. Nuclear/cytoplasmic fractionation
was performed on HEK293T cells transfected with (Myc-tagged)
Sip1 WT [15] or Sip1 (AxAx)2 (this study) or with (Flag-tagged)
Sip1 ZnF mutant [13] encoding constructs (Figure 6B). We then
used the nuclear lysates in the DNA pull-down experiment.
Sip1(AxAx)2 still bound to the E-box containing Xbra2 promoter
fragment, like Sip1 WT (Figure 6C); the Sip1 ZnF mutant of Sip1
did not (see also [15], tested in E-cadherin regulation in MDCK
epithelial cells), similar to what has been observed using gel-based
electromobility shift analysis [13].
Sip1 SBD Mutant, Unlike Sip1 WT, does not Display Dose-
dependent Down Regulation of TGFb and BMP-induced,
Smad-dependent Reporter Gene Response
To evaluate whether the Sip1 SBD mutant Sip1(AxAx)2 is able
to interfere with Smad-mediated gene response induced by TGFb
or BMP we performed a promoter-reporter assay based on a
luciferase construct containing a repeat of the SBE (i.e. SBE4) of
the Pai1 promoter. This construct is responsive to both TGFb and
BMP [58]. HEK293T cells were transfected with increasing
concentration of Sip1 WT or Sip1(AxAx)2 mutant encoding
plasmids together with plasmids encoding for constitutive active
forms of Alk3 or Alk4 receptors to activate the BMP or Nodal/
Activin Smad pathway, respectively (Figure 7). BMP pathway
activation showed a 5-fold increase in induction of the SBE4-based
promoter in control cells (mock vs. mock+c.a.Alk3). Sip1-WT
transfected cells showed a dose-dependent reduction in BMP-
Smad mediated promoter activation, while the Sip1 SBD mutant
Figure 3. Effect of mutagenesis of specific residues within the Sip1 SBD. Again, two orientations of the same model are depicted (see
Figure 2): panels A and A9 represent the ‘‘cartoon model’’ highlighting the structural elements present in the Sip1 SBD; panels B and B9 are surface
representation with volume occupied by the domain; C and C9 show the combination of panels A/A9 and B/B9. X,Y and Z axes are depicted showing
the orientation of the two sets of panels. No alteration of the overall structural model is seen (compared to the structure presented in Figure 2), but
the mutation significantly impairs the candidate contact surface with the Smad MH2 domain.
doi:10.1371/journal.pone.0076733.g003
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was not and in fact restored the BMP-dependent induction of the
SBE4-based promoter (Figure 7A). The same effect was observed
in cells in which Smad2 and 3 were activated by co-transfection
with c.a.Alk4 (Figure 7B). Hence, both the TGFb and BMP
responses recover when cells were transfected with the Sip1 SBD
mutant. Therefore we can conclude that Smad signaling in Sip1-
SBD mutant expressing cells and that DNA binding of the Sip1
SBD mutant are still effective.
Figure 4. Electrostatic properties of the predicted models for the SBD of Sip1 WT (panel A) and mutant (panel B). Potential
isocontours are displayed across a range of25 to +5 kT/e, depicting negative potential areas (in red). Cartoon representations of the models are also
shown, with key residues indicated in stick representation (panels A9 and B9).
doi:10.1371/journal.pone.0076733.g004
Figure 5. Overlay of Sip1 WT (cyan) and (AxAx)2 mutant (ochre) aa459–472 (panel A), highlighting the absence of polar chains
protruding from the solvent-exposed surface, and the global SBD domains (panel B). In A blue: WT SBD residues; lime: SBD residues that
are mutated to A. Arrowheads indicate highly disordered regions of the two superimposed structures.
doi:10.1371/journal.pone.0076733.g005
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Sip1-Smad Interaction in Ligand-activated Cells, as
Probed by Inclusion of the Sip1(AxAx)2 Mutant, Suggests
a Role in Transcriptional Repression of Cdh1 in Epithelial
Cells
We and others have shown that Smad3 and Sip1 join a longer
list of transcriptional regulators (e.g. Id proteins, Snail, Slug, and
the Sip1-related dEF1/Zeb1) that play a crucial role in downreg-
ulating and repressing the expression of key epithelial specific
proteins (e.g. E-cadherin, Cdh1) while upregulating mesenchymal
marker genes in EMT [17,46,59–63]. We therefore tested first
whether our aptamers could interfere with TGFb-induced EMT
in the NMe cell line [14]. However, we did not observe an
inhibition of EMT in aptamer-producing NMe cell cultures
treated with TGFb1 for 48 hours (data not shown). This could be
due to the high levels of endogenous Sip1 induced by TGFb in
these cells (as documented in [14]) in combination with the low
efficiency of transfection with the aptamer-encoding vectors in
NMe cells.
Repression of the endogenous Cdh1 promoter or a transiently
transfected Cdh1 promoter based reporter is frequently used as
functional read-out for Sip1 activity. Here, we checked whether
Sip1(AxAx)2 is still able to mediate transcriptional repression of
Cdh1 promoter driven luciferase. Cells were transfected with Sip1
WT or Sip1(AxAx)2 encoding vectors together with a vector
encoding for c.a.Alk4. The levels of the Cdh1 promoter-driven
reporter transcript were down regulated by increasing amounts of
Sip1 WT vector, and the Sip1 dose-dependent repression was
stronger upon co-transfection with c.a.Alk4 (Figure 8A). The
Sip1(AxAx)2 encoding vector was not able to repress Cdh1 in a
dose-dependent manner (Figure 8A). Co-transfection of both Sip1
plasmids (Figure 8B) at different ratios shows that Sip1(AxAx)2
inhibited the effect of Sip1 WT already at a 3:1 ratio of Sip1 WT
versus Sip1(AxAx)2. Altogether, we conclude that Sip1(AxAx)2
Figure 6. Full-length Sip1(AxAx)2 mutant no longer binds to activated Smads, while its DNA-binding property is preserved. A) Site-
specific mutagenesis of the QxVx repeats (see Results) in the SBD of full-length (Myc-tagged) Sip1 causes loss of Smad interaction in ligand-activated
cells (shown are Smad1 and Smad3). B) Sip1(AxAx)2 protein is predominantly nuclear, like WT Sip1. Lamin C was used as marker for the nuclear
fraction and Tubulin serves as control to verify the presence of cytoplasmic contamination in the lysates. C) DNA-IP using a segment encompassing
the Sip1-binding, E-box containing segment of the Xbra2 promoter demonstrated that Sip1(AxAx)2 is still able to bind to its cognate DNA target
sequence [13].
doi:10.1371/journal.pone.0076733.g006
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Figure 7. BMP/TGFb-induced activation of SBE4-based luciferase based-promoter is maintained in cells overexpressing the (AxAx)2
mutant. HEK293T cells were transfected with WT or SBD mutant Sip1 encoding plasmids in presence (+) or absence of a c.a.Alk3 (panel A) or c.a.Alk4
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works as a dominant-negative Sip1, operationally defined here as a
transcription factor still binding to DNA and at the same time
being insensitive to (c.a.Alk4) activated Smad in NMe cells.
Next, we overexpressed full-length Sip1(AxAx)2 in NMe cells
undergoing EMT [14,46], while knocking down the endogenous
levels of Sip1. For this purpose, we co-transfected the cells with
siRNA for mouse Sip1 and 1200 ng/ml Sip1 WT vector or
increasing concentrations of Sip1(AxAx)2 vector (i.e. 300, 600 and
up to 1200 ng/ml), and then stimulated the cells with TGFb for 48
hours. As shown in Figure 9, cells transfected with increasing
amounts of Sip1(AxAx)2 encoding vector showed less stress fiber
formation (1.6, 1.8 and 3.6 times less compared to the control; for
quantification, see Materials and Methods), even though the
overall morphology of the cells was not affected. The failure of
Sip1(AxAx)2 to down regulate endogenous Cdh1 transcription and
the observed reduced formation of stress fibers, a hallmark of
EMT, suggest that activated Smads have at least to co-operate
with Sip1 in the repression of certain key target genes in EMT. In
the case of the EMT gene Cdh1 it remains unclear as to whether
the Smad-Sip1 co-operation is the result of a direct interaction
between Sip1 and Smads, or not.
Probing Sip1-Smad Interaction Dependency with
SIP1(AxAx)2 ex vivo
We recently discovered that Sip1 controls in vivo (using
conditional knockout mice) and ex vivo (using forebrain slices from
mice, including from our knockout mice) the directed tangential
migration of cortical GABAergic interneurons from the medial
ganglionic eminences of the ventral part of the telencephalon to
the cortex [38]. To achieve this directed migration, interneurons
use a huge array of molecular mechanisms including motogenic
factors, guidance cues and transcription factors, including Sip1,
which is a key transcription factor for the guided migration of
these interneurons to the cortex [38]. Interestingly, Smad signaling
might co-regulate this guidance process as well because several
TGFb/BMP pathway components are expressed in the ventral
telencephalon. In addition, Smads have been suggested to function
in interneuron migration [64].
We wondered whether the directed migration of GABAergic
interneurons by Sip1 depends on the interaction of Sip1 with
Smads. In particular, we investigated whether focal electropora-
tion (see also Materials and Methods section, and [53]) of an
expression vector for Sip1(AxAx)2 could rescue the migration
deficit observed in Sip1 knockout brain slices. Vectors encoding
Sip1 WT, Sip1(AxAx)2, the Sip1 ZnF mutant, respectively, each
together with the reporter plasmid CALNL, and the reporter
plasmid on itself, were focally electroporated in organotypic brain
slices of E13.5 Sip1;RCE|Nkx2-1 mutant embryos (for a
representation of the experimental set-up, see Figure 10E). In
the latter embryos/brains, Sip1 was deleted in MGE-derived
interneurons resulting in disruption of their migration to the cortex
[38]. First, we determined which concentration of Sip1 WT vector
resulted in the most efficient rescue of the migration-arrest of the
interneurons to the Sip1 knockout cortex. Therefore, we compared
the Sip1 WT constructs at a final concentration of 1 mg/ ml,
0.5 mg/ml or 0.1 mg/ ml (mixed with the CALNL plasmid at
1 mg/ ml) versus the control plasmid (CALNL only, at 1 mg/ ml).
For each condition, we quantified the total number of RFP-
positive (RFP+, i.e. red) cells in the slice and calculated the
percentage of RFP+ neurons that could reach the cortex after 3
days of culture. Electroporation of Sip1 WT vector at a final
concentration of 0.5 mg/ ml resulted in the best rescue, i.e. the
highest fraction (in %) of RFP+ neurons in the cortex (data not
shown).
All Sip1 constructs were then used at the concentration of
0.5 mg/ ml in rescue experiments. Restoring Sip1 levels with the
electroporated Sip1 WT vector resulted in a clear rescue of the
interneuron migration/location defect (23.77%, n= 28 slices)
compared to the negative control CALNL (3.10%, n= 9 slices,
p,0.0001) (Figure 10A,D and quantification in F; see also [38]).
However, the Sip1 mutant constructs (AxAx)2 and ZnF, respec-
tively, failed to rescue (7.06%, n= 29, p,0.0001 and 4.55%,
n= 18 slices, p,0.0001 respectively) (Figure 10B,C,F). These data
indicate for the first time that the SBD of Sip1 needs to be intact
and is mandatory for a Sip1-dependent process in vivo, i.e. normal
interneuron migration in the embryonic forebrain.
Discussion
We mapped the critical residues for Smad interaction in the
Smad-interacting protein Sip1, which as DNA-binding transcrip-
tion factor is intensively studied in embryogenesis and tumorigen-
esis. Using a peptide aptamer approach along with structural
modelling we identified an important predicted a-helical structural
element of its SBD and redefine the 51 aa-long SBD (see [12]) as a
14 aa-long stretch. To our knowledge this is one of the rare
descriptions of an SBD for which constrained peptides have been
used to map specific residues mediating interaction between Smad
and a quite large SIP transcription factor. We also found that the
binding of the two classes of Smad (2/3 and 1/5/8) depend on the
same sequences within this short SBD. Furthermore, collective
mutation of four critical residues in the QxVx repeat of this short
SBD is sufficient to abolish Sip1-Smad interaction, while not
affecting the DNA-binding property of such full-length, mutant
Sip1. The identified (QxVx)2 motif in the Sip1 SBD is not present
in any other SIP SBD, including the previously proposed SBD
PNx5ahx3IPPh (where a is an acidic residue, h is an hydrophobic
residue, and x is any residue [65].
The binding with both TGFb and BMP activated Smads is
dependent on the same key residues in the Sip1SBD. Hence, based
on these results, it will be impossible to design and test, including
in vivo and ex vivo, variants of Sip1 that would bind selectively to
one of the two classes of Smad only, which would have been very
interesting tools. This means also that using the Sip1(AxAx)2
protein it will be difficult to test if and how, in cells exposed to both
TGFb and BMP signals, Sip1 achieves the appropriate eventual
response under this co-stimulation condition. The putative role of
Sip1 in balancing TGFb versus BMP Smad signaling may also be
determined by additional mechanisms, including the respective
receptor levels, Smad partner choice by other SIPs within these
cells or - more upstream in the signal transduction pathway -
Smad (out)competition (as recently reported for dual-active Activin
receptors in Drosophila; [66]). The eventual global response,
including the dominant Smad choice for Sip1, may therefore be
cell type/context dependent. Such other factors might be the level
of the expressed and/or activated Smad partners in the first place,
(panel B) receptor. Increasing concentrations of Sip1 WT plasmid result in a down regulation of BMP or TGFb induced gene response, effect that is
attenuated by co-transfection of the c.a.Alk3/Alk4 encoding plasmids. On the other hand, the Smad binding mutant Sip1(AxAx)2 is no longer able to
repress such gene response. Blots show the expression levels of the Sip1 (WT and mutant) encoding plasmids transfected. Images were acquired
using a Digital Chemiluminescence System (Bio-Rad).
doi:10.1371/journal.pone.0076733.g007
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Figure 8. Sip1(AxAx)2 represses Cdh1 promoter based reporter activity in a c.a.Alk4/activated Smad-independent and dominant-
negative, DNA-binding fashion. A) Luciferase reporter assay showing the inhibition of the transcriptional activity of the Cdh1 promoter mediated
by WT Sip1 (as already described in several studies). Upon transfection of the cells with a plasmid encoding the Sip1(AxAx)2 mutant, no repressive
effect was observed on the co-transfected Cdh1 promoter in the absence of c.a.ALK4. In addition, the WT Sip1 dose-dependent repression in the
presence of c.a.ALK4 is lost upon co-transfection of the Sip1(AxAx)2 mutant. B) Competition assay in cells co-transfected with WT Sip1 (human; Flag-
tagged) and mutant Sip1(AxAx)2 encoding plasmids at different ratios (total amount of transfected DNA in all cases is 50 ng). Restoration of the levels
of Cdh1 promoter activity is seen in the presence of the Sip1(AxAx)2 SBD mutant, which acts as a DNA-binding dominant-negative Sip1 (in terms of
Smad interaction), suggesting that the transcriptional repression mediated by Sip1 is strictly Smad-dependent and requires Smads bound as co-
factors. Error bars represent standard deviations.
doi:10.1371/journal.pone.0076733.g008
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but also the involvement of other Sip1 domains (e.g. the NIM in
Sip1 [22]), the post-transcriptional modification of Sip1 and/or
Smads, or feedback mechanisms that operate in these events.
Peptide aptamers have been used to interfere with TGFb
signaling components such as FoxH1, Lef1, CBP and SARA
[44,45]. SARA-based Smad-binding aptamers and their expres-
sion in NMuMG epithelial cells resulted in a block of TGFb-
induced EMT and an inhibition of Smad3 activity [45]. When we
transfected our aptamers in the NMe cell line, which is a
NMuMG-derived cell line producing stably and homogeneously
throughout the cell cultures high levels of E-cadherin, and then
stimulated with TGFb1 for 48 hours, we could not observe a
significant block of the EMT process. The overall levels of
endogenous E-cadherin (Cdh1) in the cultured cells persisted, and
in addition their Smad response was not affected (data not shown).
We suggest this result is due to the low efficiency of transfection in
Nme cells in the first place. Another likely cause is the previously
documented induction of the endogenous Sip1 gene following
TGFb1 treatment of and hence EMT induction in NMe cells in
the same timeframe as the one used by us here [14]. SARA-
derived aptamers may successfully impair EMT (as reported in
[45]) because in this case a unique SIP and upstream (cytoplasmic)
effector is targeted whose activity is mainly to present TGFb-Smad
to the receptor complex. Doing so, SARA promotes Smad
phosphorylation by the type I receptors at the early endosome
level [67], which amplifies the signaling. On the other hand,
activation of the TGFb pathway in epithelial cells can lead to
expression of other transcription factor encoding genes than Sip1,
i.e. those encoding bHLH factors (like Twist), Snail/Slug, and the
Sip1-related, non-Smad binding protein dEF1 (also named Zeb1
and Zfhx1a), suggesting co-operation and likely an hierarchy in
EMT regulation. Interestingly, Snail also binds to the Smad3/4
complex [68], making a similar structural analysis of its SBD as the
one done here for Sip1 and their co-operation in Cdh1 regulation
very interesting, and both Snail and Sip1 gene transcription are also
regulated by Smad signaling. In addition, it has been shown that
re-expression of epithelial markers as well as re-establishment of
epithelial morphology in NMuMG cells that have undergone
EMT occur only when both Sip1 and the related dEF1 protein,
and the Rho pathway, are inhibited [17]. Others and we have
already shown that Smad3 is necessary for TGFb-induced EMT
[46,59]. In our case, targeting Sip1-Smad2/3 interaction in EMT
in the NMe cell line, even when we would be able to achieve high
efficiency via transfection (or viral transduction), would then not
affect the activity of some of these other transcription factors and
hence abrogate neither EMT nor TGFb-promoted tumorigenesis.
Figure 9. Smad-Sip1 interaction is active during TGFb-induced EMT in NMe cells. Reduction of endogenous Sip1/Zfhx1b levels using
specific siRNAs (A–C) and rescue using WT Sip1 (D). Different concentrations of Sip1(AxAx)2 (E–G) or ZnF (F) mutant encoding plasmids do not show a
marked inhibition of the EMT process in TGFb1-stimulated cells. Only a significant reduction in the formation of actin stress fibers (graph in panel I)
could be observed with increasing concentration of the Sip1(AxAx)2 mutant. Blue DAPI; green: F-actin; red: anti-Sip1 (panels A–C), anti-myc (panels
D–G), anti-Flag (panel H). Panels A9 to H9 show the stress fibers images quantified (see Materials and Methods for details) in panel H. *p,0.05;
**p,0.01, Student t-test.
doi:10.1371/journal.pone.0076733.g009
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The connection between Sip1 binding and activated Smad
binding to the Cdh1 regulatory region has thus far not been directly
shown. Furthermore, the Sip1/Zeb2-related protein dEF1/Zeb1a
also downregulates Cdh1, but does not detectably bind to Smads
(our unpublished data), suggesting that - at least in some epithelial
cells - the Zeb family members down regulate Cdh1 in a Smad-
independent manner after TGFb-Smad mediated EMT has been
induced at the level of other target genes for Smad. In line with
this, Sip1 and dEF1 have been found to be necessary, but not
sufficient, for TGFb-induced EMT in NMuMG cells, requesting
the upstream action of the TGFb-induced transcription factor
encoding gene Ets-1 [69]. A Smad-binding motif is however
present in Cdh1 at +46, still in the untranslated region of the gene.
This sequence is highly conserved both in human and mouse.
Whether Sip1 and Smad are simultaneously bound to these Cdh1
regions and – if they form a complex here – who influences who in
such complex is still an intriguing question. We have previously
published evidence - in the process of myelination – that BMP-
Smad activated genes become down regulated/repressed in the
presence of and in conjunction with Sip1 [39]. However, we find
here – using the Sip1 SBD mutant constructed in this study – for
the first time that an intact SBD is needed in Sip1 to down regulate
endogenous Cdh1 transcription in conditions of TGFb pathway
activation (using c.a.Alk4).
The multi-functionality and versatility, including interaction
with many SIPs, of Smad proteins are impressive. Indeed, tens of
different SIPs bind to Smads via very diverse Smad-binding
primary sequences. Interestingly, the majority of the SIPs for
which a similar study has been done as ours here, share in their
SBD the same structural element, i.e. an a-helix that is crucial for
binding of the SIP to Smad. Our 3D modelling of the Sip1 SBD
reveals that this short domain may fold on itself, forming a hinge-
like structure, and that the exposed part is a-helical. The key
residues in this short a-helix seem to play a role as gatekeeper, as
they protrude from the surface. Schiro and co-workers [54] have
also reported that in the MH2 domain of Smad3 the residue Y298
Figure 10. GABAergic interneuron migration to the cortex is mediated by Sip1 in a Smad-dependent way. The focal electroporation
experiment is schematically represented in panel E (for more details, see Materials & Methods, and see van den Berghe et al., 2013). Sip1 WT or Sip1
SBD domain mutant construct (AxAx)2, and ZnF, were co-electroporated with a conditional dsRed-encoding plasmid (CALNL) to mark targeted cells in
Sip1;RCE|Nkx2-1 brain slices (E13.5). After 3 days in vitro (DIV), only 3.10% 60.73% (n= 9 slices) of the Sip1 KO interneurons in the control condition
(CALNL only) is able to reach the cortex compared to 23.77% 62.06% (n= 28 slices) when a Sip1 WT construct is electroporated. The Sip1 domain
mutants are not able to rescue the interneuron migration, Sip1(AxAx)2 mutant: 7.0660.77% (n= 29 slices) and Sip1 ZnF mutant: 4.55% 60.75%
(n = 18 slices). Quantification is shown in panel F. Error bars represent the SEM of 2 independent experiments, *p,0.0001, Chi-square test.
doi:10.1371/journal.pone.0076733.g010
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is crucial for binding with Sip1, and that mutation of Y226, V356
and W406, resulted in reduced binding of Smad3 to SARA, Ski
and Sip1 SBDs. These residues reside in the hydrophobic corridor
of the MH2 domain [54]. When we docked in silico our predicted
model with the MH2 domain of Smad3 (pdb: 1MK2), Q461 and
Q465 of Sip1 SBD are suggested to fit in this corridor and be able
to mediate the interaction with the MH2 domain (data not shown).
For this reason, we mutated these residues within full-length Sip1
and tested whether we could interfere with Sip1-Smad interaction
and at the same time preserve the functionality of the other
domains of Sip1, in particular the DNA-binding. The results
confirmed the essential role of these residues for mediating binding
of Sip1 with activated Smads. We also conclude that the Sip1-SBD
mutant Sip1(AxAx)2 no longer binds to type I receptor (Alk4)
activated Smad(s). It works as a dominant-negative in this respect,
but is still a DNA-binding Sip1.
Recently we described a key-role for Sip1 during migration of
GABAergic interneurons to the cortex during mouse brain
development [38]. These neurons originate mainly in the MGE
of the embryonic ventral telencephalon and follow precise paths to
the cortex, subject to attractive cues and repulsive cues (including
Unc5b-mediated ones, see [38]), where they establish essential
inhibitory connections with excitatory projection neurons. This
phenotype can be rescued both in vivo by conditional, MGE-
specific Sip1 transgene expression and ex vivo by focal electropo-
ration of Sip1 WT vectors in embryonic forebrain slices ([38: van
den Berghe, Conidi, Seuntjens and Huylebroeck, unpublished
results). Importantly, the Smad-binding deficient Sip1(AxAx)2
mutant could not rescue interneuron migration to the cortex.
We therefore conclude that the crucial role of Sip1 in precise
interneuron migration and cue interpretation is dependent on the
presence of and interaction of Sip1 with activated Smads. Further
in vivo and ex vivo work in the interneuron field is needed to
document whether modulation of essential genes along the entire
migratory route, or a part of this trajectory, of cortical interneuron
is subject to TGFb signaling via Smads in general and the SBD of
Sip1 in particular. Both TGFb and BMP signaling may take place
in this brain region: indeed, focal electroporation of dominant
negative forms of Smad1, Smad2 and Smad4 resulted in a
decreased cell migration to the cortex [64].
Taken together, our study identifies within the intensively
studied SIP-TF Sip1 a structural element and short sequence that
mediates Sip1-Smad interaction. The subtle Sip1(AxAx)2 SBD
mutant constructed here still binds to its cognate target DNA
sequences, but no longer binds to Smad proteins. This Sip1
mutant provides an important new tool to identify Smad-
(in)dependent processes as well as target genes resulting from
obligatory Sip1-Smad interaction, either in cell culture, ex vivo or in
a conditional knock-in mouse model. Approaches that involve
screening of co-expressed cDNAs or miRNAs, or of natural or
synthetic compounds, which interfere with Sip1-Smad interaction
in cultured cells, would also benefit from inclusion of this mutant
in these experiments.
Supporting Information
Figure S1 Initial model of the Sip1 SBD obtained by
homology prediction and crucial residues for Sip1
interaction on MH2 domain of Smad3. A) dvpra1a.pdb
representation. The 459–472 region is part of a longer a-helix. B)
Residues (depicted in orange) of the MH2 domain of Smad3 (pdb:
1MK2) important for interaction with Sip1 and other SIPs
according Schiro et al. (2012) [54].
(TIF)
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